Brief: Adicet Reports Q4 And Full Year 2022 Financial Results And Highlights Recent Company Progress
15/03/2023 20:04
March 15 (Reuters) - Adicet Bio Inc ACET.O :
* ADICET REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
* Q4 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwc2Vh6ma
Further company coverage: ACET.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary